BioCryst Pharmaceuticals Inc (BCRX) – Company Profile and SWOT Analysis
- Pages: 57
- Published: May 2024
- Report Code: MLPH66540FSA
BioCryst Pharmaceuticals Inc (BCRX) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
BioCryst Pharmaceuticals Inc (BioCryst) is a biotechnology company that designs, optimizes and develops small molecule drugs that block critical enzymes in the pathogenesis of diseases. The company focuses on the treatment of rare diseases and develops drugs for infectious diseases and hereditary angioedema. BioCryst’s products include peramivir injections, which consist of Rapivab, Alpivab, Rapiacta, Orladeyo and Peramiflu for the treatment of Influenza. The company’s other pipeline products include, BCX10013 and Avoralstat. It integrates the disciplines of biology, crystallography, medicinal chemistry and computer modeling to discover and develop small molecule pharmaceuticals through a process known as structure-guided drug design. BioCryst is headquartered in Durham, North Carolina, the US.
Scope
• Detailed information on BioCryst Pharmaceuticals Inc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting BioCryst Pharmaceuticals Inc in the form of a SWOT analysis
• An in-depth view of the business model of BioCryst Pharmaceuticals Inc including a breakdown and examination of key business segments
• News about BioCryst Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of BioCryst Pharmaceuticals Inc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess BioCryst Pharmaceuticals Inc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on BioCryst Pharmaceuticals Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
F. Hoffmann-La Roche Ltd
Daiichi Sankyo Co Ltd
Velico Medical Inc
GSK plc
Gilead Sciences Inc
Arbutus Biopharma Corp
Ionis Pharmaceuticals Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.